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Abstract
Mycobacterium timonense is a non-tuberculous mycobacteria
(NTM) described in southern France in 2009, and to our
knowledge, not reported again as a human pathogen in indexed
literature. The aim of this work was to characterize the first
clinical isolate of M. timonense in Ecuador. Time of growth,
biochemical tests, thin layer growth test, PCR-RFLP analysis of the
hsp65 gene and MALDI-TOF spectra analysis were not able to
identify the species. The species identification was achieved
through sequencing of rrs, hsp65 and rpoB genes. The results
highlight the necessity to set up a sequencing method to identify
emerging NTM in Ecuadorian clinical facilities.
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The Mycobacterium genus comprises around 157 species, some
of which are highly pathogenic to both humans and animals [1].
Non-tuberculous mycobacteria (NTM) are diverse and ubiqui-
tous in the environment [2]. Human-human transmission is
rare, while most of the infections are acquired by aerolization,
ingestion or contact with injured tissue [3]. The mycobacte-
rium avium complex (MAC) is the principal NTM associated
with human infections in immunocompromised and elderly
patients; this complex includes Mycobacterium avium, Mycobac-
terium intracellulare and recently Mycobacterium chimaerera,
Mycobacterium colombiense, Mycobacterium arosiense, Mycobac-
terium vulneris,Mycobacterium marseillense,Mycobacterium bouch-
edurhonense and Mycobacterium timonense [4]. The methods
commonly used for NTM species identification in Ecuadorian
hospitals, such as biochemical tests, thin layer growth test,
PCR-RFLP analysis (PRA) of the Hsp65 gene and MALDI-TOF,
are not able to identify the recently described species of the
MAC, such as M. timonense, for which sequencing is necessary.
To our knowledge, since the description of M. timonesnse in
southern France in 2009, no cases of human infection
associated with this pathogen have been reported in the
indexed literature. We describe the first isolation and charac-
terization of M. timonense from an HIV patient.
Colonies were isolated from a synovial fluid sample and
membrane biopsy from a 44-year-old man with AIDS, classi-
fication C3 (viral load, 207 000 copies/mL and CD4: 3) with
highly active antiretroviral therapy (HAART). The patient had
arthritis of the right elbow so he was treated at the
Traumatology Service of Vozandes Hospital in Quito, Ecuador.
The samples were inoculated in Lowenstein-Jensen slants and
the MGIT 960 system, because the Ziehl-Neelsen stain (AFB)
was positive in both samples. After 10 days of incubation, the
MGIT detected growth, while small colonies were observed
with the Lowenstein-Jensen method. A routine thin layer
growth and biochemical tests were carried out manually.
The DNA of the isolate (denominated NTMZ&Z1) was
obtained using the High Pure PCR template preparation kit
(Roche Diagnostic, Schweiz, Switzerland). DNA was subjected
to PRA analysis [5]. Separate aliquots of PCR amplification of
the 441 bp of the hsp65 gene were digested with BstEII and
HaeIII, and resolved in 2% agarose gel. Restriction patterns
observed were compared with Chimara et al. [5].
MALDI-TOF analysis was carried out in a Microflex LT
MALDI-TOF spectrometer (Bruker Daltonics Inc., Bremen,
Germany). The spectrum was examined in a MALDI-TOF
Biotyper v. 3.1.
The PCR fragments of 1500 bp of the rrs, 441 bp of the
hsp65 and 733pb of the rpoB gene were sequenced at the
Macrogen (Korea) facilities. Sequences were run against MAC
sequences deposited in the GenBank. Sequence alignment and
a UPGMA tree (bootstrap with 1000 replicates) of the
concatenated sequences (2542 bp: 1428 bp of the rrs,
707 bp of the rpoB and 407 bp of the hsp65 gene) were built
using Geneiuos v.7.0.6.
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The isolate was identified as M. chelonae/M. peregrinum by
routine biochemical tests. Thin layer test showed a unique
growth pattern (Fig. 1a) and MALDI-TOF analysis showed a
high score (2.095), but was not able to differentiate between
M. chimera and M. intracellulare (Fig. 1b). The PRA pattern was
very similar to M. chimaera and M. intracellulare according to
the algorithm described by Chimara et al. [5] and M. marseil-
lense according to Wallace et al. [6] (Fig. 1c). Finally, the
sequences of rrs (KJ364652), rpoB (KJ364653) and hsp65
(KJ364654) genes showed 100% identity with M. timonense in
Blast analysis and a UPGMA tree generated using concatenated
sequences (Fig. 1d, Table 1).
The mycobacterium avium complex is primarily pulmonary
pathogens that affect individuals who are immune compro-
mised (AIDS, immunosuppressive chemotherapy and hairy cell
leukaemia). In this clinical setting, the MAC has been associ-
ated with osteomyelitis, tenosynovitis, synovitis and dissemi-
nated disease involving the lymph nodes, the central nervous
system, the liver, the spleen and the bone marrow. The MAC
comprises the most common pathogens causing infection by
NTM in patients with AIDS. M. avium is isolated in more than
95% of patients with AIDS who develop MAC infections [7,8].
Still, the epidemiology of distinct species of the MAC is not
completely understood [9]. Recently, nine species have been
described within the MAC, all of them with clinical implica-
tions. However, lack of genotyping techniques available has
been one of the main reasons why there are very few data
available on species from this complex [9]. This could be
illustrated by the results obtained using the most common
methods applied in Ecuadorian clinical facilities, which could
not distinguish between several species of Mycobacterium
(Table 1, Fig. 1).
Single and concatenated sequences of rrs, rpoB and hsp65
genes strongly suggest that the isolate found in the present
(a)
(c)
(b)
(d)
FIG. 1. Results of different identification methods used in strain NTMZ&Z1. (a) Thin layer growth pattern. (b) Matrix-assisted laser desorption/
ionization-time-of-flight (MALDI-TOF) spectra. (c) PCR-RFLP analysis (PRA) pattern; L1, 25 bp ladder; L2, 1 kb ladder; BstEII digestion profile: 1,
231 bp; 2, 116 bp and 3, 94 bp fragments; HaeIII digestion profile: 4, 145 bp; 5, 127 bp; 6, 59 bp; 7, 40 bp, 36 bp and 34pb fragments. These
fragments are the result of digestion of two separate aliquots of the 441pb hsp65 PCR fragment. (d) 2542pb concatenated sequences; rrs (1420pb),
rpoB (707pb) and hsp65 (407pb) unweighted pair group method with arithmetic mean (UPGMA) tree.
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study wasM. timonense. Bootstrap values had high support in all
nodes in the UPGMA tree, confirming that these genes provide
high resolution for identification of species of the MAC. A
similar strategy has been used in order to identify emerging
pathogen Mycobacterium species [10] (Fig. 1). The lack of
success in Mycobacterium identification by healthcare facilities
could be obscuring our knowledge of the real distribution and
epidemiology of NTM strains at a global scale. This is relevant as
understanding the distribution and epidemiology would be the
first step in trying to assess differences in virulence between
some of the newly described members of the MAC.
This is one of the first global reports since the species was
described in 2009 [11]. We described an opportunistic
infection caused by M. timonense in an AIDS patient, who
was treated with ethambutol, clarithromycin and levofloxacin
for 6 months. The outcome was favourable. This report has
relevance from an epidemiological perspective because it
suggests that MAC species in HIV patients are a potential
source of infections and should be routinely screened for and
identified by sequencing. Countries in the region have found
novel MAC species (Mycobacterium colombiense) causing infec-
tions in immunocompromised individuals [12]. As far as we
know, most hospitals do not routinely screen for and identify
NTM in our country, and the very little information that is
generated in terms of epidemiology of this group of bacteria
has not been published in the indexed literature. Moreover,
non-sequence-based methods, which are commonly used in
most Ecuadorian hospitals, are not able to distinguish between
related NTM species. In this context, our findings suggest that
many standard methods for identifying Mycobacteria could be
misleading for accurate species identification of the MAC and
encourage us to recommend the use of sequence methods to
identify these pathogens in local clinical facilities.
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